Literature DB >> 33850253

Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target.

Satoshi Nakamura1,2, Hiroshi Igaki3,4, Masashi Ito5, Shoji Imamichi3,6, Tairo Kashihara4, Hiroyuki Okamoto7,3, Shie Nishioka7,3, Kotaro Iijima7, Takahito Chiba7,8, Hiroki Nakayama7,8, Mihiro Takemori7,8, Yoshihisa Abe3,9, Tomoya Kaneda4, Kana Takahashi4, Koji Inaba4, Kae Okuma4, Naoya Murakami4, Yuko Nakayama4, Mitsuko Masutani3,6,10, Teiji Nishio11, Jun Itami3,4.   

Abstract

An accelerator-based boron neutron capture therapy (BNCT) system employing a solid-state Li target can achieve sufficient neutron flux for treatment although the neutron flux is reduced over the lifetime of its target. In this study, the reduction was examined in the five targets, and a model was then established to represent the neutron flux. In each target, a reduction in neutron flux was observed based on the integrated proton charge on the target, and its reduction reached 28% after the integrated proton charge of 2.52 × 106 mC was delivered to the target in the system. The calculated neutron flux acquired by the model was compared to the measured neutron flux based on an integrated proton charge, and the mean discrepancies were less than 0.1% in all the targets investigated. These discrepancies were comparable among the five targets examined. Thus, the reduction of the neutron flux can be represented by the model. Additionally, by adequately revising the model, it may be applicable to other BNCT systems employing a Li target, thus furthering research in this direction. Therefore, the established model will play an important role in the accelerator-based BNCT system with a solid-state Li target in controlling neutron delivery and understanding the neutron output characteristics.

Entities:  

Year:  2021        PMID: 33850253     DOI: 10.1038/s41598-021-87627-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  4 in total

1.  Neutron capture therapy with boron in the treatment of glioblastoma multiforme.

Authors:  L E FARR; W H SWEET; J S ROBERTSON; C G FOSTER; H B LOCKSLEY; D L SUTHERLAND; M L MENDELSOHN; E E STICKLEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1954-02

2.  The possible use of slow neutrons plus boron10 in therapy of intracranial tumors.

Authors:  W H SWEET; M JAVID
Journal:  Trans Am Neurol Assoc       Date:  1951

3.  A revised boron-neutron capture therapy for malignant brain tumours. I. Experience on terminally ill patients after Co-60 radiotherapy.

Authors:  H Hatanaka; K Sano
Journal:  Z Neurol       Date:  1973

4.  Boron neutron capture therapy for murine malignant gliomas.

Authors:  S C Saris; G R Solares; D E Wazer; G Cano; S E Kerley; M A Joyce; L S Adelman; O K Harling; H Madoc-Jones; R G Zamenhof
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

  4 in total
  2 in total

Review 1.  A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond.

Authors:  Yoshitaka Matsumoto; Nobuyoshi Fukumitsu; Hitoshi Ishikawa; Kei Nakai; Hideyuki Sakurai
Journal:  J Pers Med       Date:  2021-08-23

2.  Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients.

Authors:  Hiroshi Igaki; Naoya Murakami; Satoshi Nakamura; Naoya Yamazaki; Tairo Kashihara; Akira Takahashi; Kenjiro Namikawa; Mihiro Takemori; Hiroyuki Okamoto; Kotaro Iijima; Takahito Chiba; Hiroki Nakayama; Ayaka Takahashi; Tomoya Kaneda; Kana Takahashi; Koji Inaba; Kae Okuma; Yuko Nakayama; Kazuaki Shimada; Hitoshi Nakagama; Jun Itami
Journal:  Clin Transl Radiat Oncol       Date:  2022-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.